A Form 4 filed with the SEC on August 4, 2026 discloses that Thomas E. Chorman, a director of Standex International Corp/DE/ (NYSE: SXI), sold 50 shares of common stock on August 3, 2026 pursuant to a pre-established 10b5-1 trading plan.

Key Highlights

  • Reporting person: Thomas E. Chorman, identified as a Director of Standex International Corp/DE/
  • Transaction: Sale (Code S) of 50 shares of common stock on August 3, 2026
  • Sale price: $305.56 per share
  • Remaining ownership: 12,366 shares of common stock held directly following the transaction
  • Trading plan: Sale made pursuant to a 10b5-1 trading plan dated November 6, 2025
  • Filing date: August 4, 2026, signed by Alan J. Glass

Chorman's Share Sale Details and Beneficial Ownership Position

According to the filing, Thomas E. Chorman, a director at Standex International Corp/DE/, disposed of 50 shares of the company's common stock on August 3, 2026 at a price of $305.56 per share. The transaction is recorded under Transaction Code S, indicating a sale. The filing notes the transaction was carried out under an existing Rule 10b5-1 trading plan, originally dated November 6, 2025.

The filing discloses that following the reported sale, Chorman directly beneficially owns 12,366 shares of Standex International common stock. No derivative securities transactions were reported in Table II of the filing. The Form 4 was filed on August 4, 2026, one day after the transaction date, and was signed by Alan J. Glass on behalf of the reporting person.

The filing indicates the sale was made "pursuant to existing 10b5-1 trading plan dated November 6, 2025," as stated in the Explanation of Responses. No other transactions or security classes were reported in this filing.

What Was Disclosed

The filing reports a single sale of 50 shares of Standex International common stock by director Thomas E. Chorman at $305.56 per share on August 3, 2026, executed under a pre-established 10b5-1 plan, leaving him with 12,366 shares held directly.